Anne Tsampalieros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anne Tsampalieros has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
A Tu
Ottawa)
1 shared publication- Alexa Marr
Department of Pediatrics, Windsor Regional Hospital , 1995 Lens Avenue, Windsor, ON, Canada N8W 1L9
1 shared publication - Alexandra Ahmet
Division of Endocrinology, Children's Hospital of Eastern Ontario and Department of Pediatrics University of Ottawa Ottawa Ontario Canada
1 shared publication Andrea Msc Wood
Physiotherapy Department RHCYP NHS Lothian, Edinburgh, United Kingdom
1 shared publication- Anna Halpin-McCormick
University of Hawai'i at Manoa
1 shared publication Cara McQuaid
Department of Pediatric Critical Care, University of Ottawa, Ottawa, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 13
Using an Electronic Medical Record to Evaluate Pediatric Blood Pressure Follow-Up: Limitations of Automated Data Extraction in a Nephrology Cohort
Background: Hypertension is a prevalent condition in the pediatric population. Diagnosis and management can be challenging. The widespread adoption of electronic medical records (EMRs) has revealed their potential for improving patient care and research. Objectives: This study used EMR data from the nephrology clinic at a single center to identify, evaluate, and monitor children with elevated blood pressure. Specifically, we attempted to assess whether documented clinical management following elevated blood pressure readings in clinic could be accurately identified using automated EMR-derived data, including whether a follow-up visit was scheduled, if the patient was sent back to their family physician, if a diagnosis of white-coat hypertension was made, or if pharmacological or non-pharmacological management for hypertension was initiated. Design: We performed a single center, retrospective cohort study using EMR data. Setting: Children who had their initial referral visit at the nephrology clinic between January 1st, 2018, and January 1st, 2022. Methods: Outpatients were identified using ICD-10 codes related to nephrology diseases. The EMR was reviewed to extract anthropometric and blood pressure (BP) data. A BP index was calculated using systolic and diastolic BP values and the 2017 American Academy of Pediatrics (AAP) hypertension guidelines. Supplemental chart review was performed only for patients with incomplete follow-up documentation following automated data extraction to assess concordance between EMR-derived data and documented clinical management. The primary analysis examined EMR data to determine whether elevated BP was appropriately managed based on available documentation, including scheduling follow-up visits, diagnosing white-coat hypertension, or initiating pharmacological or non-pharmacological interventions. Results: A total of 1,469 children aged 1–18 (median age 9.8 years) were newly referred to the nephrology clinic with complete data for BP index calculation. Many children (71/147 after visit 2, and 10/44 after visit 3) who initially had elevated BP were normotensive on their subsequent visits. Among patients with elevated BP across multiple visits, a substantial proportion had missing or incomplete longitudinal data following EMR extraction (∼20%). In addition, among patients with elevated BP after the first visit, approximately 30% did not have subsequent follow up visits documented in the EMR. Targeted manual chart review revealed that a substantial proportion of these patients had documented follow-up or BP-related management that was not captured through automated EMR extraction. Children presenting with isolated elevated diastolic BP elevations had fewer BP measurements and were less likely to have BP-related follow up, potentially reflecting the perceived benign nature of this phenomenon. Limitations: This study’s retrospective, non-randomized design limits generalizability. Conclusions: This study identifies important challenges in using EMR-derived data to study pediatric hypertension, particularly with respect to incomplete longitudinal capture and insufficient BP measurements. By integrating EMR-derived data with targeted manual chart review, we demonstrated that a substantial proportion of appropriate clinical management was not captured through automated data extraction. This underscores the importance of validating EMR-based analyses when assessing clinical care processes, as highlighted in relation to BP.
- 22 September 2026
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 13
Open AccessUsing an Electronic Medical Record to Evaluate Pediatric Blood Pressure Follow-Up: Limitations of Automated Data Extraction in a Nephrology Cohort
Background: Hypertension is a prevalent condition in the pediatric population. Diagnosis and management can be challenging. The widespread adoption of electronic medical records (EMRs) has revealed their potential for improving patient care and research. Objectives: This study used EMR data from the nephrology clinic at a single center to identify, evaluate, and monitor children with elevated blood pressure. Specifically, we attempted to assess whether documented clinical management following elevated blood pressure readings in clinic could be accurately identified using automated EMR-derived data, including whether a follow-up visit was scheduled, if the patient was sent back to their family physician, if a diagnosis of white-coat hypertension was made, or if pharmacological or non-pharmacological management for hypertension was initiated. Design: We performed a single center, retrospective cohort study using EMR data. Setting: Children who had their initial referral visit at the nephrology clinic between January 1st, 2018, and January 1st, 2022. Methods: Outpatients were identified using ICD-10 codes related to nephrology diseases. The EMR was reviewed to extract anthropometric and blood pressure (BP) data. A BP index was calculated using systolic and diastolic BP values and the 2017 American Academy of Pediatrics (AAP) hypertension guidelines. Supplemental chart review was performed only for patients with incomplete follow-up documentation following automated data extraction to assess concordance between EMR-derived data and documented clinical management. The primary analysis examined EMR data to determine whether elevated BP was appropriately managed based on available documentation, including scheduling follow-up visits, diagnosing white-coat hypertension, or initiating pharmacological or non-pharmacological interventions. Results: A total of 1,469 children aged 1–18 (median age 9.8 years) were newly referred to the nephrology clinic with complete data for BP index calculation. Many children (71/147 after visit 2, and 10/44 after visit 3) who initially had elevated BP were normotensive on their subsequent visits. Among patients with elevated BP across multiple visits, a substantial proportion had missing or incomplete longitudinal data following EMR extraction (∼20%). In addition, among patients with elevated BP after the first visit, approximately 30% did not have subsequent follow up visits documented in the EMR. Targeted manual chart review revealed that a substantial proportion of these patients had documented follow-up or BP-related management that was not captured through automated EMR extraction. Children presenting with isolated elevated diastolic BP elevations had fewer BP measurements and were less likely to have BP-related follow up, potentially reflecting the perceived benign nature of this phenomenon. Limitations: This study’s retrospective, non-randomized design limits generalizability. Conclusions: This study identifies important challenges in using EMR-derived data to study pediatric hypertension, particularly with respect to incomplete longitudinal capture and insufficient BP measurements. By integrating EMR-derived data with targeted manual chart review, we demonstrated that a substantial proportion of appropriate clinical management was not captured through automated data extraction. This underscores the importance of validating EMR-based analyses when assessing clinical care processes, as highlighted in relation to BP.
- 11 February 2025
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 26 (4) , e531-e543
Systematic Review and Meta-Analysis of Prevalence and Population-Level Factors Contributing to Posttraumatic Stress Disorder in Pediatric Intensive Care Survivors
OBJECTIVES: In survivors of illnesses or surgeries requiring PICU admission, there is a risk of posttraumatic stress disorder (PTSD). We aimed to estimate PTSD prevalence and potential contributing factors in survivors of PICU admission. DATA SOURCES: We performed a PROSPERO registered systematic review (CRD42022348997; Registered August 2022) using MEDLINE, Embase, CINAHL, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, 2000 to 2022, with no language restrictions. STUDY SELECTION: Observational or interventional studies evaluating the incidence or prevalence of PTSD in patients’ after PICU admission and/or contributing factors to PTSD. We used studies describing patients younger than 18 years old. Since there were a large number of citations, we used an integrated crowdsourcing and machine-learning model for citation screening. Each citation was reviewed independently and in duplicate by two reviewers at each stage of screening and abstraction. DATA EXTRACTION: Data items included study and participant demographics, details of case definition (PTSD screening), and risk factors. DATA SYNTHESIS: We followed the Preferred Reporting items for Systematic Reviews and Meta-analysis guidelines. Random-effects models were used to analyze PTSD prevalence and subgroup differences. In 24 citations meeting final review criteria, 19 had data for meta-analysis. There were 1898 PICU survivors with a median (interquartile range) cohort size of 59 (49–76). PTSD prevalence in the studies ranged from 3% to 37%; PTSD occurred in 529 of 1898 survivors (I 2 = 72%). Factors influencing PTSD variability included timing of assessment (p < 0.01) with the highest prevalence (29%) at 6 months and the type of assessment instrument (n = 10; range, 4–27%; p = 0.04). There was lower prevalence of PTSD (8%) in postoperative cardiac patients (p < 0.01). Last, we failed to find an association between PICU length of stay and PTSD prevalence (p = 0.62; I 2 = 80%). CONCLUSIONS: PICU follow-up studies from 2000 to 2022 indicate that one-in-three of admissions surviving to 6 months have PTSD. However, there are population, study design factors and heterogeneity in PTSD assessment that indicate more standardization in this research is needed.
- 11 February 2025
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 26 (4) , e531-e543
Systematic Review and Meta-Analysis of Prevalence and Population-Level Factors Contributing to Posttraumatic Stress Disorder in Pediatric Intensive Care Survivors
OBJECTIVES: In survivors of illnesses or surgeries requiring PICU admission, there is a risk of posttraumatic stress disorder (PTSD). We aimed to estimate PTSD prevalence and potential contributing factors in survivors of PICU admission. DATA SOURCES: We performed a PROSPERO registered systematic review (CRD42022348997; Registered August 2022) using MEDLINE, Embase, CINAHL, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, 2000 to 2022, with no language restrictions. STUDY SELECTION: Observational or interventional studies evaluating the incidence or prevalence of PTSD in patients’ after PICU admission and/or contributing factors to PTSD. We used studies describing patients younger than 18 years old. Since there were a large number of citations, we used an integrated crowdsourcing and machine-learning model for citation screening. Each citation was reviewed independently and in duplicate by two reviewers at each stage of screening and abstraction. DATA EXTRACTION: Data items included study and participant demographics, details of case definition (PTSD screening), and risk factors. DATA SYNTHESIS: We followed the Preferred Reporting items for Systematic Reviews and Meta-analysis guidelines. Random-effects models were used to analyze PTSD prevalence and subgroup differences. In 24 citations meeting final review criteria, 19 had data for meta-analysis. There were 1898 PICU survivors with a median (interquartile range) cohort size of 59 (49–76). PTSD prevalence in the studies ranged from 3% to 37%; PTSD occurred in 529 of 1898 survivors (I 2 = 72%). Factors influencing PTSD variability included timing of assessment (p < 0.01) with the highest prevalence (29%) at 6 months and the type of assessment instrument (n = 10; range, 4–27%; p = 0.04). There was lower prevalence of PTSD (8%) in postoperative cardiac patients (p < 0.01). Last, we failed to find an association between PICU length of stay and PTSD prevalence (p = 0.62; I 2 = 80%). CONCLUSIONS: PICU follow-up studies from 2000 to 2022 indicate that one-in-three of admissions surviving to 6 months have PTSD. However, there are population, study design factors and heterogeneity in PTSD assessment that indicate more standardization in this research is needed.
- Open Access
- 20 September 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 45 (2) , 253-256
Hand hygiene knowledge and practices of family caregivers in inpatient pediatrics
Family caregivers are essential inpatient pediatric care partners, yet their handwashing knowledge and compliance are rarely studied. Through hand hygiene audits and self-administered questionnaires, we observed 9% compliance, significantly lower than self-reported practice. We suggest interventions to improve caregiver handwashing behaviors to decrease infection transmission risk to hospitalized children.
- 20 September 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 45 (2) , 253-256
Open AccessHand hygiene knowledge and practices of family caregivers in inpatient pediatrics
Family caregivers are essential inpatient pediatric care partners, yet their handwashing knowledge and compliance are rarely studied. Through hand hygiene audits and self-administered questionnaires, we observed 9% compliance, significantly lower than self-reported practice. We suggest interventions to improve caregiver handwashing behaviors to decrease infection transmission risk to hospitalized children.
- Open Access
- 5 June 2023
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 50 (s2) , S79
P.076 Tone management: an environmental scan of current management practices across Canada
Background: Currently, there are no standardized approaches to care or evaluation for tone dysfunction in Canada. The study authors hypothesize that there is significant practice variation across the country. This environmental scan is aimed to describe the current practice for management of patients with hypertonia across Canada. Methods: A web-based survey was developed by the authors with a multi-disciplinary approach and sent to representative rehabilitation sites in each province. All statistical analyses were performed using the R statistical software version 4.0. Results: CP was found to be the most common diagnosis for tone dysfunction, with 58% (7/12) of sites diagnosing greater than 20 new patients per year. All 12 sites offered oral baclofen and gabapentin, and 92% of sites offered trihexyphenidyl. Botulinum toxin injections were offered at 50% of sites. Upper and lower extremity procedures were offered in 83% of the sites. In 8 of 12 sites (67%), patients were seen within a formal multidisciplinary clinic to manage hypertonia. Conclusions: The information gained from this study provides some insight into the current practice across Canada for children with hypertonia. This study may assist in the development of a national, standardized strategy to tone management, potentially facilitating more equitable access to care for patients.
- 5 June 2023
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 50 (s2) , S79
Open AccessP.076 Tone management: an environmental scan of current management practices across Canada
Background: Currently, there are no standardized approaches to care or evaluation for tone dysfunction in Canada. The study authors hypothesize that there is significant practice variation across the country. This environmental scan is aimed to describe the current practice for management of patients with hypertonia across Canada. Methods: A web-based survey was developed by the authors with a multi-disciplinary approach and sent to representative rehabilitation sites in each province. All statistical analyses were performed using the R statistical software version 4.0. Results: CP was found to be the most common diagnosis for tone dysfunction, with 58% (7/12) of sites diagnosing greater than 20 new patients per year. All 12 sites offered oral baclofen and gabapentin, and 92% of sites offered trihexyphenidyl. Botulinum toxin injections were offered at 50% of sites. Upper and lower extremity procedures were offered in 83% of the sites. In 8 of 12 sites (67%), patients were seen within a formal multidisciplinary clinic to manage hypertonia. Conclusions: The information gained from this study provides some insight into the current practice across Canada for children with hypertonia. This study may assist in the development of a national, standardized strategy to tone management, potentially facilitating more equitable access to care for patients.
- Open Access
- 31 January 2022
- Published by BMJ in BMJ Open Quality
- Vol. 11 (1) , e001563
Patient and family perspectives of a Pre-Transition Visit in a paediatric tertiary care diabetes clinic
Introduction The need to better prepare youth with type 1 diabetes for the transition from paediatric to adult care is evident. As part of a regional quality improvement initiative, a novel Pre-Transition (Pre-T) Visit was developed and piloted at a paediatric tertiary care centre in January 2018 for patients aged 15–18 years to capture the status of their self-management skills, introduce transition tools and identify self-care goals and knowledge gaps to be addressed prior to transition. Purpose To evaluate patient and family satisfaction, visit relevance and patient engagement with a novel Pre-T Visit. Methods From May 2019 to March 2020 a survey was offered to all youth who attended a Pre-T Visit and their parent(s)/caregiver(s). Patient and family satisfaction with, relevance of and engagement with the Pre-T Visit were evaluated using a 5-point Likert scale. Multivariable regression was used to assess patient factors associated with patient level satisfaction. Results Of the 63 youth who participated in a Pre-T Visit, 60 completed the survey. Mean age (SD) of participants was 16.7 (0.8) years; 47% were female. Mean (SD) haemoglobin A1C (A1C) was 8.2% (1.8). Patients reported high levels of satisfaction (95% quite or extremely satisfied) that were consistent across age, A1C, gender and disease duration. Visit relevance and engagement were also rated highly by youth. Parent participants (n=27) also reported high levels of satisfaction (89% quite or extremely satisfied) and relevance. Conclusions Pre-T Visits were rated highly by patients and their parents. Their impact on glycaemic control and health outcomes following transition requires further study.
- 31 January 2022
- Published by BMJ in BMJ Open Quality
- Vol. 11 (1) , e001563
Open AccessPatient and family perspectives of a Pre-Transition Visit in a paediatric tertiary care diabetes clinic
Introduction The need to better prepare youth with type 1 diabetes for the transition from paediatric to adult care is evident. As part of a regional quality improvement initiative, a novel Pre-Transition (Pre-T) Visit was developed and piloted at a paediatric tertiary care centre in January 2018 for patients aged 15–18 years to capture the status of their self-management skills, introduce transition tools and identify self-care goals and knowledge gaps to be addressed prior to transition. Purpose To evaluate patient and family satisfaction, visit relevance and patient engagement with a novel Pre-T Visit. Methods From May 2019 to March 2020 a survey was offered to all youth who attended a Pre-T Visit and their parent(s)/caregiver(s). Patient and family satisfaction with, relevance of and engagement with the Pre-T Visit were evaluated using a 5-point Likert scale. Multivariable regression was used to assess patient factors associated with patient level satisfaction. Results Of the 63 youth who participated in a Pre-T Visit, 60 completed the survey. Mean age (SD) of participants was 16.7 (0.8) years; 47% were female. Mean (SD) haemoglobin A1C (A1C) was 8.2% (1.8). Patients reported high levels of satisfaction (95% quite or extremely satisfied) that were consistent across age, A1C, gender and disease duration. Visit relevance and engagement were also rated highly by youth. Parent participants (n=27) also reported high levels of satisfaction (89% quite or extremely satisfied) and relevance. Conclusions Pre-T Visits were rated highly by patients and their parents. Their impact on glycaemic control and health outcomes following transition requires further study.
- 1 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 297 (3) , 565-572
Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis
Gadoxetic acid had similar risk for hypersensitivity reactions and nephrogenic systemic fibrosis (NSF) compared with group 2 gadolinium-based contrast agents, but with lower confidence for NSF risk... Background Gadoxetic acid is classified by the American College of Radiology as a group III gadolinium-based contrast agent (GBCA), which indicates that there are limited data regarding nephrogenic...
- 1 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 297 (3) , 565-572
Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis
Gadoxetic acid had similar risk for hypersensitivity reactions and nephrogenic systemic fibrosis (NSF) compared with group 2 gadolinium-based contrast agents, but with lower confidence for NSF risk... Background Gadoxetic acid is classified by the American College of Radiology as a group III gadolinium-based contrast agent (GBCA), which indicates that there are limited data regarding nephrogenic...
- 28 June 2019
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (11) , 2361-2370
Obstructive sleep apnea and hypertension in pediatric chronic kidney disease
Children with chronic kidney disease (CKD) are at risk for obstructive sleep apnea (OSA) and hypertension. The objectives of this study were to explore associations between OSA severity using the apnea-hypopnea-index(AHI) and obstructive apnea-hypopnea-index(OAHI) on polysomnography (PSG), OSA symptoms, and measures of hypertension in children with CKD.
- 28 June 2019
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (11) , 2361-2370
Obstructive sleep apnea and hypertension in pediatric chronic kidney disease
Children with chronic kidney disease (CKD) are at risk for obstructive sleep apnea (OSA) and hypertension. The objectives of this study were to explore associations between OSA severity using the apnea-hypopnea-index(AHI) and obstructive apnea-hypopnea-index(OAHI) on polysomnography (PSG), OSA symptoms, and measures of hypertension in children with CKD.
- Open Access
- 1 January 2019
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 6
The Effect of Transplant Volume and Patient Case Mix on Center Variation in Kidney Transplantation Outcomes
Background: Kidney transplantation is the optimal treatment for patients with end-stage renal disease; however, long-term outcomes remain suboptimal. Objective: The objectives of our study were to examine the variation in survival rates and determine whether center volume and case mix are associated with transplant outcomes and explain the variation across kidney transplant centers in Ontario, Canada. Design: This was a population-based cohort study using health care administrative databases. Setting: A total of 5 transplant centers across Ontario, Canada. Patients: We included adults (≥18 years) undergoing primary, solitary kidney transplantation between January 1, 2000 to December 31, 2013. Measurements: The co-primary outcomes were death-censored graft loss and total mortality. Methods: Multivariable Cox proportional hazards regression was used to assess potential associations and describe variation, using hazard ratios (HRs) with 95% confidence intervals (CIs) for each center relative to the average across all centers. Results: The study cohort included 5037 patients followed for a median of 5.3 years, interquartile range (2.7-8.6). In multivariable models, recipient age, body mass index, Charlson Index, time on dialysis, donor type, and age were found to be significantly associated with death-censored graft loss, and recipient age and sex, Charlson Index, time on dialysis, donor age, and time era of transplant were associated with total mortality. There was statistically significant variation across centers observed for death-censored graft loss ( P = .04) with HRs ranging from 0.72 to 1.22. However, neither adjusting for case mix nor center volume meaningfully changed the HRs reflecting each center-specific effect. There was a tendency toward reduced risk of graft loss (HR, per additional 25 patients, 0.90 [95% CI, 0.78-1.04]) in centers with higher volumes. For total mortality, there was statistically significant variation across centers with HRs ranging from 0.82 to 1.13 ( P = .04); however, neither adjusting for case mix or center volume meaningfully changed the HRs. Center volume was not significantly associated with total mortality (HR, per additional 25 patients, 1.04 [95% CI, 0.90-1.20]). Limitations: This study was limited by the small number of centers included. Conclusions: Outcomes differ across the 5 transplant centers in Ontario. We did not find any strong support for our hypotheses that case mix or center volume is responsible for these differences.
- 1 January 2019
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 6
Open AccessThe Effect of Transplant Volume and Patient Case Mix on Center Variation in Kidney Transplantation Outcomes
Background: Kidney transplantation is the optimal treatment for patients with end-stage renal disease; however, long-term outcomes remain suboptimal. Objective: The objectives of our study were to examine the variation in survival rates and determine whether center volume and case mix are associated with transplant outcomes and explain the variation across kidney transplant centers in Ontario, Canada. Design: This was a population-based cohort study using health care administrative databases. Setting: A total of 5 transplant centers across Ontario, Canada. Patients: We included adults (≥18 years) undergoing primary, solitary kidney transplantation between January 1, 2000 to December 31, 2013. Measurements: The co-primary outcomes were death-censored graft loss and total mortality. Methods: Multivariable Cox proportional hazards regression was used to assess potential associations and describe variation, using hazard ratios (HRs) with 95% confidence intervals (CIs) for each center relative to the average across all centers. Results: The study cohort included 5037 patients followed for a median of 5.3 years, interquartile range (2.7-8.6). In multivariable models, recipient age, body mass index, Charlson Index, time on dialysis, donor type, and age were found to be significantly associated with death-censored graft loss, and recipient age and sex, Charlson Index, time on dialysis, donor age, and time era of transplant were associated with total mortality. There was statistically significant variation across centers observed for death-censored graft loss ( P = .04) with HRs ranging from 0.72 to 1.22. However, neither adjusting for case mix nor center volume meaningfully changed the HRs reflecting each center-specific effect. There was a tendency toward reduced risk of graft loss (HR, per additional 25 patients, 0.90 [95% CI, 0.78-1.04]) in centers with higher volumes. For total mortality, there was statistically significant variation across centers with HRs ranging from 0.82 to 1.13 ( P = .04); however, neither adjusting for case mix or center volume meaningfully changed the HRs. Center volume was not significantly associated with total mortality (HR, per additional 25 patients, 1.04 [95% CI, 0.90-1.20]). Limitations: This study was limited by the small number of centers included. Conclusions: Outcomes differ across the 5 transplant centers in Ontario. We did not find any strong support for our hypotheses that case mix or center volume is responsible for these differences.